BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 30594980)

  • 1. [Effects of miR-143 on the migration and invasion of osteosarcoma cells by regulating MMP-13 expression].
    Li B; Li ZP; Lian ZG
    Zhongguo Gu Shang; 2023 Nov; 36(11):1075-80. PubMed ID: 38012878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
    Thanindratarn P; Li X; Dean DC; Nelson SD; Hornicek FJ; Duan Z
    J Orthop Res; 2020 Apr; 38(4):902-910. PubMed ID: 31736134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis.
    Chang YH; Huang YL; Tsai HC; Chang AC; Ko CY; Fong YC; Tang CH
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2.
    Niu F; Zhao S; Xu CY; Sha H; Bi GB; Chen L; Ye L; Gong P; Nie TH
    Oncol Lett; 2015 Oct; 10(4):2415-2421. PubMed ID: 26622862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients.
    Robinson P; Rosso M; Muñoz M
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression" [Int. Immunopharmacol. 24(1) (2015) 50-58].
    Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
    Int Immunopharmacol; 2024 Mar; 129():111493. PubMed ID: 38311512
    [No Abstract]   [Full Text] [Related]  

  • 7. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.
    Zhang W; Huang X; Huang R; Zhu H; Ye P; Lin X; Zhang S; Wu M; Jiang F
    Comput Math Methods Med; 2022; 2022():3058342. PubMed ID: 36105241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma.
    Jubelin C; Muñoz-Garcia J; Cochonneau D; Moranton E; Heymann MF; Heymann D
    Cancer Drug Resist; 2022; 5(1):184-198. PubMed ID: 35582537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway.
    Xu C; Wang Z; Zhang L; Feng Y; Lv J; Wu Z; Yang R; Wu T; Li J; Zhou R; Tian Z; Bai J; Zhang H; Lan Y; Lv Z
    Cancer Cell Int; 2022 Jan; 22(1):34. PubMed ID: 35057799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody.
    Tsai MT; Sun YS; Keerthi M; Panda AK; Dhawan U; Chang YH; Lai CF; Hsiao M; Wang HY; Chung RJ
    Nanomaterials (Basel); 2021 Dec; 12(1):. PubMed ID: 35010011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
    Abdel-Hamid NM; Abass SA
    Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells.
    Behera A; Ashraf R; Srivastava AK; Kumar S
    Heliyon; 2020 Sep; 6(9):e04820. PubMed ID: 32984578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Hybrid Peptides: A Novel Drug Design Approach.
    Wang C; Yang C; Chen YC; Ma L; Huang K
    Curr Med Sci; 2019 Jun; 39(3):349-355. PubMed ID: 31209802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro.
    Tang ML; Bai XJ; Li Y; Dai XJ; Yang F
    Curr Med Sci; 2018 Oct; 38(5):809-817. PubMed ID: 30594980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway.
    Yue B; Ren QX; Su T; Wang LN; Zhang L
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2640-7. PubMed ID: 25317798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment.
    Salvatore V; Focaroli S; Teti G; Mazzotti A; Falconi M
    Oncotarget; 2015 Oct; 6(30):28988-98. PubMed ID: 26418748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
    Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
    Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
    Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.